We developed a recombinant vaccine and generated a potentially patentable discovery for a leading laboratory in Latin America

{"ops":[{"insert":"Benten Biotech announced the results of an advanced biotechnology development project undertaken for one of Latin America's leading veterinary vaccine manufacturers. The development of a recombinant vaccine targeting the predominant global genotype not only achieved the established technical and health objectives but also led to an unexpected discovery with patentable potential.\n\nThis case reflects an increasingly common reality in modern biotechnology: when development is approached with scientific rigor and molecular precision, the value generated transcends the final product and can become a strategic innovation asset.\n\nA global health challenge addressed with precision recombinant biotechnology"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nThe laboratory sought to develop a recombinant vaccine targeting the predominant global genotype in a context where traditional approaches presented technical and biological limitations in achieving consistent levels of immunogenicity, stability, and productive performance.\n\nBenten Biotech was engaged to design and execute the development from an applied R&D perspective, integrating molecular knowledge, industrial criteria, and a vision focused on scalability and technological robustness.\n\nFrom Rational Design to Validated Recombinant Development"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nThe project progressed through a structured framework that included:\n\nAnalysis of the health challenge and the target genotype."},{"attributes":{"list":"ordered"},"insert":"\n"},{"insert":"Rational design of the recombinant antigen."},{"attributes":{"list":"ordered"},"insert":"\n"},{"insert":"Development of the expression and production system."},{"attributes":{"list":"ordered"},"insert":"\n"},{"insert":"Iteration of the design based on the results obtained."},{"attributes":{"list":"ordered"},"insert":"\n"},{"insert":"\nThis approach enabled the generation of a vaccine candidate aligned with the technical and regulatory standards of a large-scale veterinary vaccine manufacturing laboratory.\n\nAn Unforeseen Finding That Opened an Intellectual Property Opportunity"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nDuring development, the Benten Biotech team identified a biological behavior and a design element that were not part of the project's initial objective but revealed a clear opportunity for technological innovation.\n\nThe finding was communicated to the client, who evaluated it with their internal team and their law firm specializing in intellectual property. The analysis confirmed that the discovery meets the patentability criteria, and it is currently in the formal patenting process.\n\nBeyond the Vaccine: Creating Technological Value for the Client"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nIn addition to fulfilling the project's original objective, this development generated additional value for the laboratory:\n\nA recombinant vaccine candidate targeting the predominant global genotype."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"A patentable discovery currently being protected."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"A technological asset with potential for future applications."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"A sustainable competitive advantage within its vaccine portfolio."},{"attributes":{"list":"bullet"},"insert":"\n"},{"insert":"\nThis result demonstrates how a well-executed biotechnology development can become a source of strategic value beyond the immediate product.\n\nApplied Biotechnology with an Industrial and Innovation Vision"},{"attributes":{"header":2},"insert":"\n"},{"insert":"\nAt Benten Biotech, we believe that modern biotechnology is not limited to solving specific health challenges, but must build innovation platforms, capabilities, and assets for our clients.\n\nThis case illustrates our ability to work alongside major veterinary vaccine manufacturers, integrating ourselves as technology partners and contributing applied science with immediate impact and a long-term vision.\n"}]}